Board of Directors

Frank Chen

Chairman and CEO

Vice President of Investment Management Department, Ruentex Group Special Assistant to President, Ruentex Group Master of Business Administration, National Taiwan University Bachelor of Chemical Engineering, National Taiwan University

Heidi Wang


Chief Executive Officer, OBI Pharma, Inc. Head of Global Regulatory Sciences Oncology, Bristol-Myers Squibb (BMS) Company Postdoctoral Training, Cold Spring Harbor Laboratory in New York, USA M.S. and a Ph.D., University of Notre Dame in Indiana, USA

Chung Yao Yin


Chairman, Nan Shan Life Insurance Co. Ltd. Chairman, Nan Shan Life Charity Foundation Board Member, Nan Shan General Insurance Co. Ltd. Board Member, Ruentex Development Co. Ltd. Board Member, Ruentex Industries Co. Ltd. Board Member, Ruentex Material Co. Ltd. Board Member, Ruentex Enginering & Construction Co. Ltd. Board Member, Gogoro Inc. Board Member, Tang Prize Foundation Board Member, Yin Shu-Tien Memorial Hospital PhD. University of Oxford

Jo Shen


Venture Partner Vivo Capital Co-Founder Executive Director, Taiwan Bio Industry Organization Independent Board Member, Lumosa Therapeutics Board Member, Formosa Pharmaceuticals, Inc. Advisor, National Health Research Institutes Advisor, Lifemax Biotechnology, Inc. Advisor, Merry Life Biomedical Co. Ltd.

Hsin Min Chen


Advisory Committee Member, Prevention and treatment of infectious diseases, Ministry of Health and Welfare General Manager, Intelligent-Bio Co. Ltd. Vice Chairman, Asia - Pacific Biosafety Association Doctor of Philosophy, University of Rhode Island

Colin Kao


Finance Director, OBI Pharma, Inc. Certified Public Accountant, Taiwan Certified Public Accountant, AIA, UK International Certified Internal Auditor Master of Accounting, National Chengchi University Bachelor of Accounting, National Chengchi University